MC1R and cancer: Moreover, the strategy to develop new molecules and formulations acting on the different skin cell populations through PPARγ is expected to be beneficial in preventing cutaneous UV damage and cancer, by augmenting DNA repair and antioxidant defence, and stimulating melanogenesis, particularly in high-risk individuals, e.g. those harbouring MC1R mutations.